By Chris Hutching
Friday 27th October 2000
|Text too small?|
C G Surgical's 10 million shares were issued at 8c recently and Southern Capital bought one million of them. A few early trades last week saw the shares change hands at 60c but this week a parcel of 5000 shares was traded at $1.70.
South Island businessman Mr Paterson, who is a founder shareholder and director of Southern Capital, identified the opportunity to invest in C G Surgical through his links with Otago University researchers.
Other recent fledgling bio-tech companies where Southern Capital has stakes include Blis, which owns patents over a cure for throat infections, and A2 Corporation, which claims patents over milk proteins that may have significance for some health conditions. After initial stagging on Blis and A2 shares issued at 10c, trades have settled to a narrower range around 80c and $2.30, still representing considerable paper profits for Southern Capital.
Managing director Graeme Wong said Southern Capital was retaining its stakes for now.
C G Surgical was developed by engineer Richard Cathro. It has patents over a titanium and teflon clip which prevents pressure on the spinal cord. Pressure can cause neurological-related complaints.
No comments yet
MARKET CLOSE: NZ shares rise, Scales and Mercury gain while Comvita drops on earnings
NZ dollar falls ahead of milk auction
CORRECTION:Heartland lifts first-half profit 14%, ups share purchase plan
NZX's Superlife swaps notes for 71% of Energy Mad
Former Ministry of Transport senior manager sentenced to jail for fraud
Joyce unveils first social bond pilot in pitch to get more productive public service
Colonial Motor Co reports a 5.2% dip in 1H profit
Caltex cuts dividend to pay for Gull acquisition in search for regional growth
Comvita turns to a first-half loss as Chinese crackdown hurts sales
UPDATE: Mercury reports 53% jump in 1H net profit, lifts FY guidance